Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Gliclaz M 80 mg/500 mg Tablet

Prescription Icon
Prescription Required

Marketer

Khandelwal Laboratories Pvt Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Gliclaz M 80 mg/500 mg Tablet

Diabexe Duo 80mg/500mg tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This formulation helps regulate blood glucose. Diabexe Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Prompt glucose intake (e.g., sugary foods or juice) is crucial if hypoglycemia occurs. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation. Regular blood glucose monitoring is essential, alongside potential blood tests to assess blood cell counts and liver function.

Primary Ingredients of Gliclaz M 80 mg/500 mg Tablet

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Gliclaz M 80 mg/500 mg Tablet

Diabetes mellitus type 2

Major Benefits of Gliclaz M 80 mg/500 mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Gliclaz M 80 mg/500 mg tablets with meals.

Common Side effects of Gliclaz M 80 mg/500 mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Gliclaz M 80 mg/500 mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Gliclaz M 80 mg/500 mg tablet should be administered with a meal.

How Gliclaz M 80 mg/500 mg Tablet works:

Each Gliclaz M 80 mg/500 mg tablet contains gliclazide and metformin, two medications used to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Gliclaz M 80 mg/500 mg tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Gliclaz M 80 mg/500 mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's not recommended. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Gliclaz M 80 mg/500 mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gliclaz M 80 mg/500 mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Gliclaz M 80 mg/500 mg tablets. Physician consultation is essential. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gliclaz M 80 mg/500 mg tablets cautiously, potentially requiring dosage modification. Individuals with mild to moderate liver disease should begin with a low dose; however, this medication is unsuitable for those with severe liver disease. Medical advice is essential.

What if you forget to take Gliclaz M 80 mg/500 mg Tablet :

Should you forget a Gliclaz M 80 mg/500 mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gliclaz M 80 mg/500 mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gliclaz M 80 mg/500 mg Tablet

Gliclaz M 80 mg/500 mg tablets combine gliclazide and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Gliclaz M 80 mg/500 mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Gliclaz M 80 mg/500 mg Tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Gliclaz M 80 mg/500 mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Gliclaz M 80 mg/500 mg tablets can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Gliclaz M 80 mg/500 mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining alcohol and Gliclaz M 80 mg/500 mg tablets is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Gliclaz M 80 mg/500 mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Gliclaz M 80 mg/500 mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Gliclaz M 80 mg/500 mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Gliclaz M 80 mg/500 mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Gliclaz M 80 mg/500 mg Tablets and seek immediate medical attention.
Prolonged use of Gliclaz M 80 mg/500 mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Gliclaz M 80 mg/500 mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining alcohol with Gliclaz M 80 mg/500 mg tablets is unsafe. This combination can dangerously lower blood sugar and raise the risk of lactic acidosis.
Gliclaz M 80 mg/500 mg Ta...
103
MRP 125
17% off